Pacira BioSciences, Inc. (NasdaqGS:PCRX) announces a share repurchase program. Under the program, the company will repurchase up to $150 million worth of its common stock. The company expects to fund the share repurchase program using a combination of existing cash reserves and future cash flows.
The repurchase program will expire on December 31, 2026.